3B BlackBio Dx Limited (formerly Kilpest India Limited) has announced the launch of its Second 100-Day Campaign titled 'Saksham Niveshak' aimed at helping shareholders update their KYC details and claim unpaid dividends before they are transferred to the Investor Education and Protection Fund (IEPF).

Campaign Details and Timeline

The Second 100-Day Campaign 'Saksham Niveshak' will run from April 1, 2026 to July 9, 2026. The campaign has been launched pursuant to guidelines issued by the Investor's Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs (MCA).

KYC Update Requirements

Shareholders holding shares in physical form are advised to update their KYC details with the company's Registrar and Share Transfer Agent (RTA). The required updates include:

• PAN details
• Bank account information
• Address with PIN code
• Mobile number
• Specimen signatures
• Nomination details

Registrar and Transfer Agent Information

Shareholders can update their details through Adroit Corporate Services Private Limited, the company's RTA:

Required Forms and Resources

The relevant forms for updating KYC and nomination details can be downloaded from multiple sources:

• Forms ISR-1, ISR-2, ISR-3, and SH-14 are available on the RTA website at https://www.adroitcorporate.com/RandTServices.aspx
• Forms can also be downloaded from the company's website at https://www.kilpest.com/investor.html
• Shareholders holding shares in Demat form should update their KYC and bank account details with their respective Depository Participants

Dividend Claims and IEPF Transfer Prevention

The campaign's primary objective is to facilitate direct payment of unpaid/unclaimed dividends to rightful shareholders and prevent the transfer of such amounts to the IEPF. The company has uploaded details of unpaid/unclaimed dividends for the past seven years on its website under the "Investor Info" section at https://www.kilpest.com .

Company Contact Information

For additional assistance, shareholders can reach out to the company at info@kilpest.com . The notice was issued by Nikhil Kuber Dubey, Whole Time Director (DIN: 00538049), and published in Business Standard (English) and Swadesh Jyoti Bhopal (Hindi) on April 4, 2026, in compliance with Regulation 30 of SEBI Listing Regulations.

3B BlackBio Dx Limited has successfully concluded its scheduled analyst meeting with Fair Value Capital (India Insight Value Fund) on March 17, 2026. The virtual one-on-one interaction, which began at 4:00 PM, concluded at 4:50 PM, lasting 50 minutes as part of the company's regulatory compliance framework.

Meeting Outcome and Duration

The company formally notified BSE Limited about the successful completion of the analyst meeting through regulatory filing Ref. No.P-66/2025-26/83 dated March 17, 2026. This follows the earlier notification filed under reference P-66/2025-26/82 dated March 12, 2026, which had announced the scheduled meeting.

Information Sharing and Compliance

During the investor meeting, 3B BlackBio Dx Limited reiterated information from its Q3-FY26 investor presentation, which was previously communicated to stock exchanges through reference P66/2025-26/74 dated February 6, 2026. The company emphasized that only publicly available information was discussed, with no unpublished price sensitive information shared with the investor.

The presentation used during the meeting has been made accessible through the company's website at the following link: https://www.kilpest.com/upload/Investors%20Presentation%20February%202026.pdf . This presentation was originally placed before investors after the declaration of financial results for the quarter and nine months ended December 31, 2025.

Regulatory Framework and Documentation

The meeting was conducted under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The outcome communication was digitally signed by Nikhil Kuber Dubey, Whole Time Director (DIN: 00538049), on March 17, 2026 at 4:58 PM, demonstrating the company's commitment to timely regulatory reporting.

3B BlackBio Dx Limited, formerly known as Kilpest India Limited, continues to maintain transparency in its investor relations activities while ensuring strict adherence to regulatory guidelines for information sharing during institutional interactions.